PS
IBRN icon

Principal Securities’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Principal Securities’s Portfolio IBRN Stock Details IBRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-732
Closed -$19.6K – 2359
2025
Q3 		$19.6K Hold
732
– – ﹤0.01% 2410
2025
Q2 		$16K Hold
732
– – ﹤0.01% 2425
2025
Q1 		$18.6K Hold
732
– – ﹤0.01% 2233
2024
Q4 		$18.6K Hold
732
– – ﹤0.01% 2231
2024
Q3 		$18.3K Buy
+732
New +$18.3K ﹤0.01% 2163

Other funds holding IBRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Principal Securities's IBRN Position: Q4 2025 in Review

Principal Securities sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q4 2025, closing a stake of 732 shares — an estimated $19.6K sold.

Principal Securities first reported a position in IBRN in Q3 2024 and held it in 5 quarters. The position peaked at $19.6K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBRN as of Q4 2025.

  • Principal Securities reported no remaining iShares Neuroscience and Healthcare ETF position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 732 iShares Neuroscience and Healthcare ETF shares in Q4 2025, an estimated $19.6K.
  • Principal Securities first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2024 and held it in 5 quarters.
  • Principal Securities's iShares Neuroscience and Healthcare ETF position peaked at $19.6K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.